Bessemer Group
HPTX

Bessemer Group’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Bessemer Group’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-50
Closed -$2K – 1677
2015
Q1 		$2K Hold
50
– – ﹤0.01% 1452
2014
Q4 		$1K Hold
50
– – ﹤0.01% 1473
2014
Q3 		$1K Hold
50
– – ﹤0.01% 1237
2014
Q2 		$1K Buy
+50
New +$1.28K ﹤0.01% 1392

Bessemer Group's HPTX Position: Q2 2015 in Review

Bessemer Group sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 50 shares — an estimated $2K sold.

Bessemer Group first reported a position in HPTX in Q2 2014 and held it in 4 quarters. The position peaked at $2K in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • Bessemer Group reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Bessemer Group sold 50 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $2K.
  • Bessemer Group first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2014 and held it in 4 quarters.
  • Bessemer Group's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $2K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Bessemer Group's 13F filing for Q2 2015, filed 14 Aug 2015.